Policy / Regulatory

NMPA Publishes 110th Batch of Chemical Generic Drug Reference Listed Drug Catalog – 28 New Specifications Added

NMPA Publishes 110th Batch of Chemical Generic Drug Reference Listed Drug Catalog – 28 New Specifications Added

The National Medical Products Administration (NMPA) has released the 110th batch of the Catalog of Reference Listed Drugs (RLD) for Chemical Generic Drugs, adding 28 new drug specifications and providing…

NMPA Proposes Drug Market Exclusivity Framework – Up to Seven Years for Rare Disease Therapies and Two Years for Pediatric Drugs

NMPA Proposes Drug Market Exclusivity Framework – Up to Seven Years for Rare Disease Therapies and Two Years for Pediatric Drugs

MOFCOM and MOST Open Consultation on Revised Technology Export Catalogue – 40 Technologies Across AI, Biopharmaceuticals and Photovoltaics Proposed for Addition

MOFCOM and MOST Open Consultation on Revised Technology Export Catalogue – 40 Technologies Across AI, Biopharmaceuticals and Photovoltaics Proposed for Addition

Empowering Chinese Pharma’s Global Expansion

Leverage premier media reach to connect your pipeline with global partners. Contact us to drive your international growth today.
Contact US
NHSA 2025 Drug Catalog Review: 6 Drugs Rejected, 718 Applications Reviewed
Nationally negotiated drugsNHSA (prev. SMIA)

NHSA 2025 Drug Catalog Review: 6 Drugs Rejected, 718 Applications Reviewed

China's NMPA Resumes Import of Vasudha's Loratadine API After Rectifications
NMPAVasudha Pharm Chem

China’s NMPA Resumes Import of Vasudha’s Loratadine API After Rectifications

InnoCare Pharma's ICP-723 Joins China's SPARK Project for Pediatric Solid Tumors
CDEHKG: 9969

InnoCare Pharma’s ICP-723 Joins China’s SPARK Project for Pediatric Solid Tumors

China Releases Draft Guidelines for Single-Arm Oncology Trials to Support Drug Approvals

China Releases Draft Guidelines for Single-Arm Oncology Trials to Support Drug Approvals

Show More